Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy

Jort Merken*, Mark Hazebroek, Pieter Van Paassen, Job Verdonschot, Vanessa Van Empel, Christian Knackstedt, Myrurgia Abdul Hamid, Michael Seiler, Julian Kolb, Philipp Hoermann, Christian Ensinger, Hans-Peter Brunner-La Rocca, Gerhard Poelzl, Stephane Heymans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number004228
Number of pages8
JournalCirculation-Heart Failure
Volume11
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • heart failure
  • immunosuppression
  • inflammatory cardiomyopathy
  • prognosis
  • ANCA-ASSOCIATED VASCULITIS
  • GIANT-CELL MYOCARDITIS
  • DILATED CARDIOMYOPATHY
  • ENDOMYOCARDIAL BIOPSY
  • CONTROLLED-TRIAL
  • HEART-FAILURE
  • DIAGNOSIS
  • AZATHIOPRINE
  • MAINTENANCE
  • PREDNISONE

Cite this